1. Peripheral metabolism of (R)-[11C] verapamil in epilepsy patients;Abrahim;Eur. J. Nucl. Med. Mol. Imaging,2008
2. Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up;Agarwal;Curr. Pharm. Des.,2011
3. Ashworth, P.A., Hunjan, S., Pretswell, I.A., Ryder, H., Brocchini, S.J., 1996. Piperazine-2,5-dione Derivatives as Modulators of Multidrug Resistance. PCT Int. Appl. WO 96/20180.
4. Bang, K.C., Cha, M.Y., Ahn, Y.G., Ham, Y.J., Kim, M.S., Lee, G.S., 2005. P-glycoprotein Inhibitor, Method for Preparing the Same and Pharmaceutical Composition Comprising the Same. PCT Int. Appl. WO 2005/033097 A1.
5. A novel PET imaging protocol identifies seizure-induced regional overactivity of P-glycoprotein at the blood–brain barrier;Bankstahl;J. Neurosci.,2011